BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 15753051)

  • 1. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors.
    Murata M; Harada M; Kato S; Takahashi S; Ogawa H; Okamoto S; Tsuchiya S; Sakamaki H; Akiyama Y; Kodera Y
    Bone Marrow Transplant; 1999 Nov; 24(10):1065-71. PubMed ID: 10578156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
    Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
    Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
    Becker PS; Wagle M; Matous S; Swanson RS; Pihan G; Lowry PA; Stewart FM; Heard SO
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):45-9. PubMed ID: 9209740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.
    Cesaro S; Marson P; Gazzola MV; De Silvestro G; Destro R; Pillon M; Calore E; Messina C; Zanesco L
    Haematologica; 2002 Aug; 87(8 Suppl):35-41. PubMed ID: 12412388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
    Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor.
    Mori T; Sato N; Watanabe R; Okamoto S; Ikeda Y
    Bone Marrow Transplant; 2000 Jul; 26(2):239-40. PubMed ID: 10918440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
    Nuamah NM; Goker H; Kilic YA; Dagmoura H; Cakmak A
    Haematologica; 2006 May; 91(5 Suppl):ECR08. PubMed ID: 16709516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor produces a decrease in IFNgamma and increase in IL-4 when administrated to healthy donors.
    Rodríguez-Cortés O; Vela-Ojeda J; López-Santiago R; Montiel-Cervantes L; Reyes-Maldonado E; Estrada-García I; Moreno-Lafont MC
    J Clin Apher; 2010; 25(4):181-7. PubMed ID: 20818712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.